ACWASXActinogen Medical Ltd

ACW price activity

Last Price

Change (24hr)

AUD (%)

Volume

Volume (4w avg)

Previous Close

N/A

Last Trade

ACW price performance

12,2%

-24,59%

YTD

53,33%

ACW price fundamentals

N/A

Shares Issued

N/A

Earnings Per Share (EPS)

N/A

Dividends Per Share (DPS)

N/A

P/E Ratio

Price market cap

Market cap

N/A

AU-ASX rank

N/A

Sector Rank

N/A

ACW details

View company profile

View company website

View AU-ASX Official Page

Dividendos de ACW

Ver mais

quote.marketSignals

Mais formas de descobrir

Ver notícias de Australia Descubra sinais de ASX Ver todas as ações de ASX Ver todos os ETFs de ASX

Actinogen Medical Ltd (AU-ASX: ACW)

Actinogen Medical Limited, a biotechnology company, develops therapies for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol in Australia. It develops Xanamem, an oral medication and inhibitor of the 11ß-HSD1 enzyme that achieves target engagement in the brain for the treatment of Alzheimer's disease, major depressive disorder, fragile x syndrome, and other neurological diseases. The company was formerly known as Actinogen Limited and changed its name to Actinogen Medical Limited in November 2015. Actinogen Medical Limited was incorporated in 1999 and is based in Sydney, Australia.

Price: A$0.05

Sector: Healthcare — Biotechnology